US Pharma MarketingBioNTech to slash 1,860 jobs, exit sites in Germany and Singapore in major manufacturing pullback
The German vaccine maker plans to wind down operations at a handful of its sites in Germany plus one in Singapore, putting as many as 1,860 jobs on the chopping block.
The German vaccine maker plans to wind down operations at a handful of its sites in Germany plus one in Singapore, putting as many as 1,860 jobs on the chopping block.
Source: FiercePharma